revenue for Dec 17 qrtr was already 243 million. Income Statement Mayne Pharma Group Ltd. QUARTERLY ANNUAL Net Income 070M140M Column 1 Column 2 Column 3 Column 4 Column 5 0 0-70M-140M-210M Column 1 Column 2 Column 3 Column 4 Column 5 0 Dec2015Jun2016Dec2016Jun2017Dec2017 Dec 2017 5-quarter trend 1 Net Income Growth - Column 1 0 Sales or Revenue| 243.26 M| Column 1 Column 2 Column 3 Column 4 Column 5 0 Sales or Revenue Growth| -| Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 0 EBITDA| +27.55 M| Column 1 Column 2 0 [/table]